Description

4,7-Ethano-1,3-Benzodioxole, 3A,4,7,7A-Tetrahydro-, (3A-α-,4-α-,7-α-,7A-α-)- (9Ci) is a specialized bicyclic organic compound featuring a fused dioxole and cyclohexene structure, serving as a valuable chiral synthon and building block in advanced organic synthesis. Its unique stereochemistry and functionalized framework make it a critical intermediate for constructing complex molecules with high precision. This compound is primarily sought by research institutions and industrial R&D departments in the pharmaceutical, agrochemical, and fine chemical sectors for developing novel active ingredients and functional materials.

Application

• Pharmaceutical Intermediate: Key chiral building block for the synthesis of novel drug candidates, particularly in central nervous system (CNS) and antiviral research.
• Agrochemical Synthesis: Used in the development of advanced pesticides and herbicides, leveraging its complex ring system for biological activity.
• Fine Chemical Production: Serves as a precursor for specialty chemicals, including flavors, fragrances, and advanced polymers.
• Asymmetric Catalysis Research: Employed as a ligand precursor or a test substrate in the development of new catalytic systems.
• Material Science: Investigated as a monomer or additive for creating polymers with specific optical or mechanical properties.
• Academic & Industrial R&D: Utilized in methodological studies and process chemistry for constructing complex, stereodefined molecular architectures.

Basic Information

Item	Details
Product Name	4,7-Ethano-1,3-Benzodioxole, 3A,4,7,7A-Tetrahydro-, (3A-α-,4-α-,7-α-,7A-α-)- (9Ci)
CAS No.	69956-68-9
Molecular Formula	C9H12O2
Molecular Weight	152.19 g/mol
Synonyms	1,3-Benzodioxole, 4,7-ethano-3a,4,7,7a-tetrahydro-, (3aR,4R,7R,7aR)-rel-; (3aR,4R,7R,7aR)-4,7-Ethano-1,3-benzodioxole-3a,4,7,7a(2H,5H)-tetrol; Tetrahydro-4,7-ethano-1,3-benzodioxole; Bicyclic dioxole derivative; Chiral benzodioxole synthon
EINECS	Contact for details

Quality Control

Every batch of 4,7-Ethano-1,3-Benzodioxole, 3A,4,7,7A-Tetrahydro-, (3A-α-,4-α-,7-α-,7A-α-)- (9Ci) is produced and tested under a strict quality management system. We provide comprehensive analytical data to ensure the product meets the high-purity standards required for research and synthesis. A Certificate of Analysis (COA) detailing purity, enantiomeric excess (where applicable), and impurity profiles is supplied with each shipment. Specifications can be aligned with cGMP or other relevant regulatory frameworks for advanced applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat sources and incompatible materials. For long-term storage, consider an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Enantiomeric Excess (Chiral HPLC)	≥ 99.0% (for chiral-specific grades)
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.